Clinical Trial Update: A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 randomized, double-blind study evaluating two doses of S-777469 for atopic dermatitis, assessing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• S-777469

Snippet

Sponsor: Shionogi | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED